Stonvex
Stonvex
StonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
No sell-side coverage available for LEU yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-14 | $193.00 | $192.32 | -0.35% | 0.7M |
| 05-15 | $182.01 | $182.60 | +0.32% | 0.9M |
| 05-18 | $182.60 | $172.95 | -5.28% | 1.0M |
| 05-19 | $170.00 | $169.00 | -0.59% | 0.9M |
| 05-20 | $173.00 | $169.31 | -2.13% | 0.9M |
Centrus Energy Corp is engaged in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment has two components which include the sale of separative work units and uranium. The Technical Solutions segment provides engineering, design, and manufacturing services to government and private sector customers. The majority of the firm's revenue is derived from the LEU segment. It has a business presence in the U.S. and other countries, of which prime revenue is generated in the U.S.
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $76.70M | $448.70M | $302.50M | $227.60M |
Operating Income | $800.00K | $50.20M | $37.40M | $54.00M |
Net Income | $10.00M | $77.80M | $60.00M | $28.90M |
EPS (Diluted) | $0.45 | $3.90 | $3.16 | $3.22 |
Total Assets | $2.43B | $2.45B | $2.24B | $1.31B |
Total Liabilities | $1.66B | $1.68B | $1.88B | $955.70M |
Cash & Equivalents | $1.87B | $1.96B | $1.63B | $833.00M |
Free Cash Flow OCF − CapEx | $-58.30M | $31.30M | $89.30M | $83.60M |
Shares Outstanding | 22.45M | 19.93M | 18.96M | 17.41M |
LEU is in the extended universe. We surface dollar-volume + price-change percentiles for every US-listed name, but the full 6-factor DNA breakdown (momentum, news, sentiment, flow, relative strength) is only computed on the curated 1137-name primary list.
DNA analysis is not available for this ticker.
Latest Form 13F-HR disclosures from the curated Super Investors list. Click through to see each manager's full long book.